F

Fundacion CENIT | Buenos Aires, Argentina

Research site
(Unclaimed)
Location
Juncal 2222 PB, Buenos Aires, Buenos Aires, Argentina
Site insights

Top conditions

Stomach Cancer (1 trial)

Esophageal Cancer (1 trial)

Adenocarcinoma (1 trial)

Top treatments

Trastuzumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 1
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

This study will evaluate the efficacy and safety of trastuzumab deruxtecan (T-DXd) compared with ramucirumab and paclitaxel (Ram + PTX) in participan...

Enrolling
Gastric Cancer, Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Drug: Ramucirumab
Drug: Paclitaxel

Trial sponsors

D

Daiichi Sankyo (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems